MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Integra LifeSciences Holdings Corp

Open

SectorHealthcare

20.1 -7.54

Overview

Share price change

24h

Current

Min

20.15

Max

21.72

Key metrics

By Trading Economics

Income

30M

19M

Sales

62M

443M

P/E

Sector Avg

63.02

63.778

EPS

0.97

Profit margin

4.391

Employees

4,396

EBITDA

40M

79M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+19.38% upside

Dividends

By Dow Jones

Next Earnings

5 May 2025

Market Stats

By TradingEconomics

Market Cap

-343M

1.7B

Previous open

27.64

Previous close

20.1

News Sentiment

By Acuity

50%

50%

180 / 386 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Chart

Past performance is not a reliable indicator of future results.

Related News

6 May 2024, 16:47 UTC

Earnings
Major Market Movers

Integra LifeSciences Shares Drop to Record Low on Unexpected Loss, Boston Facility Audit Findings

Peer Comparison

Price change

Integra LifeSciences Holdings Corp Forecast

Price Target

By TipRanks

19.38% upside

12 Months Forecast

Average 26 USD  19.38%

High 35 USD

Low 20 USD

Based on 7 Wall Street analysts offering 12 month price targets forIntegra LifeSciences Holdings Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

7 ratings

2

Buy

3

Hold

2

Sell

Technical Score

By Trading Central

21.69 / 22.3Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

180 / 386 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.